Lorem, Geir Fagerjord
Næss, Eva T.
Løchen, Maja-Lisa
Lillevoll, Kjersti
Molund, Else-Marie
Rösner, Assami
Lindkvist, Sigmund
Schirmer, Henrik
Funding for this research was provided by:
UiT The Arctic University of Norway
Article History
Received: 8 February 2023
Accepted: 2 December 2023
First Online: 12 December 2023
Declarations
:
: The Regional Committee for Medical and Health Research Ethics and the Norwegian Centre for Research Data have approved the Tromsø Study and this project (Case number 199331). The study followed relevant guidelines and regulations (i.e., the Helsinki Declaration, Vancouver Convention, and Norwegian legislation). We obtained informed consent from all participants.
: Not applicable.
: Maja-Lisa Løchen has received lecture fees from Bayer, Sanofi and BMS/Pfizer unrelated to this research. Henrik Schirmer has received lecture fees from Novartis and Amgen and an ongoing research collaboration with Novartis unrelated to this research. The other authors declare no financial or non-financial competing interests.